We have recently developed a protocol to obtain a soluble Candida spp. b1, 3-glucan (CSBG) by sodium hypochlorite (NaClO) oxidation and subsequent dimethyl sulfoxide (DMSO) extraction. CSBG is composed mainly of b-1,3 and b-1,6-glucosidic linkages with a small amount of branching. Antibody to b-glucan is generally difficult to produce. In the present study, the specificity of the human sera to CSBG was examined by ELISA. Using CSBG-coated plates, sera from normal human volunteers showed high reactivity that was neutralized by adding soluble CSBG as a competitor. However, the reactivity could not be neutralized by a b-1,6 branched b-1,3-glucan, grifolan. Similar specificity of the immunoglobulin (Ig) was detected in commercially available g-globulin prepared from pooled human sera. Comparing various standard glucans, a major epitope was present on b-1,6 glucan segment. Drug Dev.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.